Nuveen’s Chimerix, Inc. CMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-683,557
Closed -$861K 3313
2023
Q1
$861K Buy
683,557
+307,791
+82% +$502K ﹤0.01% 2661
2022
Q4
$699K Sell
375,766
-64,327
-15% -$126K ﹤0.01% 2806
2022
Q3
$850K Buy
440,093
+14,391
+3% +$32.3K ﹤0.01% 2817
2022
Q2
$885K Buy
425,702
+21,127
+5% +$67.9K ﹤0.01% 2842
2022
Q1
$2.06M Sell
404,575
-164,942
-29% -$919K ﹤0.01% 2489
2021
Q4
$3.66M Sell
569,517
-346,134
-38% -$2.08M ﹤0.01% 2276
2021
Q3
$5.67M Sell
915,651
-227,953
-20% -$1.57M ﹤0.01% 2131
2021
Q2
$5.7M Buy
1,143,604
+173,312
+18% +$1.44M ﹤0.01% 2179
2021
Q1
$4.83M Buy
970,292
+686,483
+242% +$6.3M ﹤0.01% 2186
2020
Q4
$1.37M Sell
283,809
-20,997
-7% -$76.1K ﹤0.01% 2686
2020
Q3
$759K Sell
304,806
-111,010
-27% -$328K ﹤0.01% 2802
2020
Q2
$1.29M Sell
415,816
-356,292
-46% -$922K ﹤0.01% 2514
2020
Q1
$1.11M Sell
772,108
-188,933
-20% -$331K ﹤0.01% 2473
2019
Q4
$1.95M Buy
961,041
+128,760
+15% +$237K ﹤0.01% 2425
2019
Q3
$1.96M Buy
832,281
+250,990
+43% +$725K ﹤0.01% 2410
2019
Q2
$2.51M Buy
+581,291
New +$1.79M ﹤0.01% 2324
2015
Q2
Sell
-2,341
Closed -$4.4M 1658
2015
Q1
$4.4M Buy
+2,341
New +$92.9K 0.02% 555

Other funds holding CMRX

Nuveen's CMRX Position: Q2 2023 in Review

Nuveen sold out of Chimerix, Inc. (CMRX) in Q2 2023, closing a stake of 683,557 shares — an estimated $861K sold.

Nuveen first reported a position in CMRX in Q1 2015 and held it in 17 quarters. The position peaked at $5.7M in Q2 2021. 96 funds tracked by Wall St. Rank hold CMRX as of Q2 2023.

  • Nuveen reported no remaining Chimerix, Inc. position as of Q2 2023 after selling out during the quarter.
  • Nuveen sold 683,557 Chimerix, Inc. shares in Q2 2023, an estimated $861K.
  • Nuveen first reported a position in Chimerix, Inc. in Q1 2015 and held it in 17 quarters.
  • Nuveen's Chimerix, Inc. position peaked at $5.7M in Q2 2021.
  • 96 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q2 2023.

Based on Nuveen's 13F filing for Q2 2023, filed 14 Aug 2023.